What is the main business of N - Symbiosis Polska?

The main business activity of N - Symbiosis Polska focuses on manufacture of pharmaceutical preparations.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on August 31, 2015.

Where is the headquarters located?

The headquarters is located at: ul. Płocka 5A, 01-231 Warszawa.

What is the share capital?

The share capital of the company is PLN 10,000 (approx. $2,701).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2018 to December 31, 2018.

What was the revenue?

In 2018, the company's revenue reached $121,129.

No, the company recorded a net loss of $20,632 in 2018.

What is the main operating cost?

The largest operating cost category falls under other operating costs. This category amounted to $55,884 in 2018, representing 40% of all operating expenses.

N - Symbiosis Polskasp. z o.o.

Manufacture of pharmaceutical preparations

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2015-08-31

Share capital

10,000.00 PLN

Activity description

N - Symbiosis Polska began operating in 2015 and used that name for its first five years; in 2021, the company changed its name to Alderma Group Polska. It sold products and disposable accessories for aesthetic medicine and cosmetology, including carboxytherapy devices, and provided training in treatment procedures.

Registered address

ul. Płocka 5A, 01-231 Warszawa, Poland

Website

n-symbiosis.com

Phone

Social media

Financials

Filing timeliness

No financial statement for 2019 – the filing deadline has passed.

2019not filed
201812/06/2019

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2018.

Results vs industry

Revenue

This companyUSD 121.13kMedianUSD 917.74kAverageUSD 25.73m

Net profit

This companyUSD -20.63kMedianUSD 14.44kAverageUSD 2.75m

Operating costs

This companyUSD 140.09kMedianUSD 860.03kAverageUSD 21.34m

Assets

This companyUSD 41.97kMedianUSD 883.09kAverageUSD 31.39m

Industry

Offer

Mesotherapy preparations
Hyaluronic acid fillers
Lifting threads
Needles and syringes
Cannulas
Mesotherapy devices
Chemical peels
Training courses

Website technology

Online shop

WooCommerce

Website

WordPress
Elementor

Analytics and marketing

Google Analytics
Google Tag Manager
Hotjar

Authorized Representatives

Grzegorz Zdzisław Szadkowski – President of the Management Board

Manner of representation

For making declarations of will concerning the company's property and non-property rights and obligations and for representing the company in and out of court, the following are authorized: in the case of a one-person management board, the President of the Management Board; in the case of a multi-member management board, the President of the Management Board and the Vice-President of the Management Board independently, or two members of the management board acting jointly.

Ownership

Owner	Shares	Share value	Stake
Grzegorz Zdzisław Szadkowskiage 36	40	$1,080.50	40%
Others	60	$1,620.75	60%

Beneficial owners

No beneficial owners recorded for the company N - Symbiosis Polska.

Bank accounts

Was a VAT taxpayer from 2015-10-14 to 2023-08-03.

Reason for removal: Art. 96 ust. 6-8

Debt

6 closed proceedings recorded in KRZ history.

Registration date	Proceeding type	Status
Sep 24, 2025	Discontinued enforcement proceedings	Closed
May 13, 2024	Discontinued enforcement proceedings	Closed
May 13, 2024	Discontinued enforcement proceedings	Closed
Apr 4, 2023	Discontinued enforcement proceedings	Closed
Aug 18, 2022	Discontinued enforcement proceedings	Closed

Public aid

No public aid cases recorded in the last 10 years.

Competitors

	Name	Revenue	Website
	Pexon Polandsp. z o.o.	$122,615.96	pexon.pl

FAQ

Last updated: 2026-04-13